Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
暂无分享，去创建一个
D. Hose | H. Goldschmidt | A. Jauch | A. Benner | A. Elmaagacli | P. Brossart | A. Seckinger | C. Scheid | D. Tichy | S. Luntz | M. Munder | U. Bertsch | H. Salwender | M. Raab | E. Mai | K. Weisel | I. Blau | S. Fuhrmann | H. Bernhard | H. Lindemann | J. Duerig | M. Goerner | M. Haenel | B. Besemer | Eva-Maria Klein | Mabast Akhavanpoor | On Behalf Of The German-Speaking Myeloma Multicent